Ritchie Centre, Hudson Institute of Medical Research, Melbourne, VIC 3168, Australia.
Department of Paediatrics, Monash University, Melbourne, VIC 3168, Australia.
Int J Mol Sci. 2023 Feb 1;24(3):2795. doi: 10.3390/ijms24032795.
Preterm birth is a major contributor to neonatal morbidity and mortality. Complications of prematurity such as bronchopulmonary dysplasia (BPD, affecting the lung), pulmonary hypertension associated with BPD (BPD-PH, heart), white matter injury (WMI, brain), retinopathy of prematurity (ROP, eyes), necrotizing enterocolitis (NEC, gut) and sepsis are among the major causes of long-term morbidity in infants born prematurely. Though the origins are multifactorial, inflammation and in particular the imbalance of pro- and anti-inflammatory mediators is now recognized as a key driver of the pathophysiology underlying these illnesses. Here, we review the involvement of the interleukin (IL)-1 family in perinatal inflammation and its clinical implications, with a focus on the potential of these cytokines as therapeutic targets for the development of safe and effective treatments for early life inflammatory diseases.
早产是新生儿发病率和死亡率的主要原因。早产儿的并发症,如支气管肺发育不良(BPD,影响肺部)、与 BPD 相关的肺动脉高压(BPD-PH,心脏)、脑白质损伤(WMI,大脑)、早产儿视网膜病变(ROP,眼睛)、坏死性小肠结肠炎(NEC,肠道)和败血症等,是早产儿长期发病的主要原因。尽管早产的原因是多因素的,但炎症,特别是促炎和抗炎介质的失衡,现在被认为是这些疾病病理生理学的关键驱动因素。在这里,我们回顾了白细胞介素(IL)-1 家族在围产期炎症中的作用及其临床意义,重点介绍了这些细胞因子作为治疗靶点的潜力,以开发安全有效的治疗早期生命炎症性疾病的方法。